Colombia's adherence to international standards makes it a 'big space' for pharma growth, says trade industry boss

13 May 2019

Learning from the standards set by the USA, Europe and Brazil, Colombia is fast catching up in making the country an attractive place to research, seek approval for and market medicines, according to Yaneth Giha Tovar (pictured above), executive president of AFRIDO, the national trade association for the pharmaceutical industry.

Talking to Angel Galindo, The Pharma Letter’s Latin America correspondent, she said that while there have been a number of initiatives involving industry, academia and government, a lot more can still be done to ensure Colombia is a country where pharmaceutical innovation thrives.

Aiming for access and regulatory improvements

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK